NPI: 1992767149 · SALEM, OR 97302 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 04/04/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 04/04/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 15,785 | $500K |
| 2019 | 14,068 | $553K |
| 2020 | 14,186 | $268K |
| 2021 | 11,249 | $265K |
| 2022 | 7,756 | $248K |
| 2023 | 5,392 | $117K |
| 2024 | 1,920 | $224K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 33,714 | 1,748 | $2.15M |
| J1756 | Injection, iron sucrose, 1 mg | 2,097 | 493 | $10K |
| J1270 | Injection, doxercalciferol, 1 mcg | 6,324 | 425 | $8K |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 18,038 | 881 | $3K |
| A4657 | Syringe, with or without needle, each | 4,681 | 1,191 | $3K |
| 83970 | 240 | 145 | $317.71 | |
| 82728 | 1,068 | 612 | $287.03 | |
| 83550 | 1,050 | 601 | $173.72 | |
| 83540 | 1,050 | 603 | $128.72 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 240 | 107 | $126.11 |
| 85041 | 833 | 468 | $57.29 | |
| 85048 | 829 | 466 | $45.32 | |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 176 | 95 | $39.53 |
| 82108 | 16 | 13 | $0.00 |